Brief Introduction
Innovating Neurological Healthcare
“At GreyMatter Pharma, we are dedicated to revolutionizing neurological healthcare. Our unique approach repurposes existing FDA-approved drugs, exploring new potentials in treating neurological conditions.”
Our Mission
Repurposing FDA-Approved Drugs
We believe in giving new life to existing drugs. Our mission includes repurposing FDA-approved medications to explore novel treatments for neurological disorders.
Maximizing Academic and Off-label Data
Utilizing a wealth of academic research and off-label usage data, we aim to uncover unexplored drug-indication fits in neurology.
Accelerated Drug Development
Our strategy involves fast-tracking drug development by leveraging available data, speeding up the journey from research to real-world application.
Utilizing Government Incentives
We strategically use government incentives and grants to fund our research, ensuring maximum return on investment and fostering innovation in drug development.